Le professeur Nils Thoennissen est un spécialiste international du cancer, des maladies dégénératives chroniques et de la médecine régénérative. Il possède plus de 20 ans d'expérience dans le domaine de la médecine factuelle et 14 ans d'expérience clinique en hémothérapie. Il est l'auteur de 40 publications scientifiques dans des revues à comité de lecture et a reçu 6 prix. Il a suivi une formation postuniversitaire à l'université de Münster, à l'école de médecine de l'université de Cardiff, à l'université de Mayence et au Cedars-Sinai Medical Center. Il occupe actuellement le poste de directeur médical de CBC Health et a précédemment occupé les fonctions de médecin-chef à l'hôpital St. George, au centre médical Kloster Paradies et au centre médical universitaire de Hambourg-Eppendorf.
Accommodation is not included
Transfer airport-clinic-airport
CBC Health is a day-clinic where the patient will get his treatment and will be released every day to the hotel.
Symptoms after a stroke: cord blood and stem cells prove their curative effect.
According to statistics, 20 to 25% of patients who survive a stroke die within the following four weeks. All others have various degrees of brain damage, ranging from mild problems in everyday life to severe symptoms requiring long-term care. Is there a way to avoid this? New methods of regenerative therapy suggest that there is.
Umbilical cord blood - therapies and stem cells for a better prognosis
As a result of a stroke, there is reactive inflammation in the brain caused by the damaged tissue. Unfortunately, this impairs the patient's recovery process and can also affect adjacent healthy brain tissue.
Here, recent meta-analyses in the field of regenerative medicine from 2022 show that it is possible to optimize prognosis after stroke has occurred (Paton MCB et al, Cytotherapy, 2022). Intravenous delivery of umbilical cord blood (UCB) may lead to improvement in this case, as the primitive cells contained in UCB may help inflammation in the brain to subside more quickly and rescue neurons that are about to die. In addition, UCB provides powerful growth factors and molecules that stimulate natural healing processes such as the formation of new synapses and neuronal circuitry.
While the efficacy of regenerative stem cell therapy has not been fully researched, there are no concerns about unexpected safety risks associated with its use. Most positively, there are no reports of immunological rejection, and UCB has an even lower risk profile than traditional blood transfusion in adults. These findings give stroke patients reason to hope for a better future.
Coordinateur médical personnel
Organisation de voyage médical — réservation des tickets de vol et des chambres d'hôtel à des prix réduits pour les partenaires
Prise en charge du patient lors d'un voyage médical